BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
350 hedge funds and large institutions have $6.06B invested in Blueprint Medicines in 2025 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 132 increasing their positions, 115 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
2% more funds holding
Funds holding: 343 → 350 (+7)
1.5% more ownership
Funds ownership: 105.7% → 107.2% (+1.5%)
4% more capital invested
Capital invested by funds: $5.85B → $6.06B (+$209M)
Holders
350
Holding in Top 10
9
Calls
$144M
Puts
$100M
Top Buyers
| 1 | +$260M | |
| 2 | +$132M | |
| 3 | +$70.8M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$59.1M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$42.9M |
Top Sellers
| 1 | -$118M | |
| 2 | -$79.5M | |
| 3 | -$60.9M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$50.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$25.7M |